Drug intelligence / Profile preview

8-prenylnaringenin

Development stage
Preclinical
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

8-prenylnaringenin is a prenylflavonoid phytoestrogen found primarily in hops (Humulus lupulus) and beer[4][15]. It is among the most estrogenic phytoestrogens known, acting as a potent agonist of the estrogen receptors, especially ERα, and to a lesser extent ERβ[1][4][10][13]. Its activity is 50–1500 times greater than genistein or daidzein but is markedly less potent than estradiol[1][4]. 8-prenylnaringenin exhibits both estrogenic and antigonadotropic activities, suppressing luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels in humans[4][7]. It has demonstrated effects similar to estradiol, including preserving bone density, reducing hot flashes, inducing prolactin secretion, and increasing other estrogenic responses[4]. Beyond endocrine effects, it displays anticancer properties in vitro, such as inhibition of proliferation and induction of apoptosis in various cancer cell lines, likely associated with inhibition of voltage-gated Kv1.3 potassium channels[1][4]. It can also enhance GABA_A receptor activity[4]. The compound is being studied as a possible alternative to hormone replacement therapy (HRT) and for management of menopause-related symptoms[1][7][9].

Other names
5,7,4'-trihydroxy-8-prenylflavanoneisobavachinflavapreninhopeinsophoraflavanone B(S)-8-dimethylallylnaringenin(+/-)-8-prenylnaringenin
02

Targets

ESR2 (ERβ)ESR1 (ERα)

Beyond the preview

Go deeper on 8-prenylnaringenin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 8-prenylnaringenin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call